171 related articles for article (PubMed ID: 33567533)
1. The Identification of Small Molecule Inhibitors That Reduce Invasion and Metastasis of Aggressive Cancers.
van de Merbel AF; van Hooij O; van der Horst G; van Rijt-van de Westerlo CCM; van der Mark MH; Cheung H; Kroon J; Verhaegh GW; Tijhuis J; Wellink A; Maas P; Viëtor H; Schalken JA; van der Pluijm G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567533
[TBL] [Abstract][Full Text] [Related]
2. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
3. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
4. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis.
Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F
Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991
[TBL] [Abstract][Full Text] [Related]
5. Effects of VEGFR1
Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
[TBL] [Abstract][Full Text] [Related]
7. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
Zhou Q; Yan B; Hu X; Li XB; Zhang J; Fang J
Mol Cancer Ther; 2009 Jun; 8(6):1684-91. PubMed ID: 19509250
[TBL] [Abstract][Full Text] [Related]
9. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
[TBL] [Abstract][Full Text] [Related]
10. A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.
Speransky S; Serafini P; Caroli J; Bicciato S; Lippman ME; Bishopric NH
Breast Cancer Res Treat; 2019 Jul; 176(2):271-289. PubMed ID: 31006104
[TBL] [Abstract][Full Text] [Related]
11. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
12. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
15. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
16. WNK1 Enhances Migration and Invasion in Breast Cancer Models.
Jaykumar AB; Jung JU; Parida PK; Dang TT; Wichaidit C; Kannangara AR; Earnest S; Goldsmith EJ; Pearson GW; Malladi S; Cobb MH
Mol Cancer Ther; 2021 Oct; 20(10):1800-1808. PubMed ID: 34253593
[TBL] [Abstract][Full Text] [Related]
17. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.
Sheng Y; Cao M; Liu Y; He Y; Zhang G; Du Y; Gao F; Yang C
Mol Cell Biochem; 2021 Sep; 476(9):3383-3391. PubMed ID: 33954907
[TBL] [Abstract][Full Text] [Related]
19. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
20. Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.
Shah GV; Muralidharan A; Thomas S; Gokulgandhi M; Mudit M; Khanfar M; El Sayed K
Mol Cancer Ther; 2009 Mar; 8(3):509-20. PubMed ID: 19276166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
